Biomarker Identified Which Can Determine Severity of Idiopathic Pulmonary Fibrosis

Nigam Shah and Purvesh Khatri, professors at Stanford University, along with graduate student Madeleine Scott have just announced results from a research study which could be pivotal for those living…

Continue Reading Biomarker Identified Which Can Determine Severity of Idiopathic Pulmonary Fibrosis
The First Adeno-Associated Viral Gene Therapy for Huntington’s Disease Receives the FDA’s Fast Track Designation
mcmurryjulie / Pixabay

The First Adeno-Associated Viral Gene Therapy for Huntington’s Disease Receives the FDA’s Fast Track Designation

  A recent article in globenewswire.com news reported that the FDA has approved Fast Track Designation for AMT 130, an experimental gene therapy for the treatment of Huntington’s disease. The…

Continue Reading The First Adeno-Associated Viral Gene Therapy for Huntington’s Disease Receives the FDA’s Fast Track Designation
Gene Therapy Could Change Rare Disease Treatment Forever, But Will Anyone be Able to Afford It?
8385 / Pixabay

Gene Therapy Could Change Rare Disease Treatment Forever, But Will Anyone be Able to Afford It?

According to a story from BNN Bloomberg, gene therapies are without a doubt an upcoming advancement in care and treatment for many diseases that have a genetic origin. This includes…

Continue Reading Gene Therapy Could Change Rare Disease Treatment Forever, But Will Anyone be Able to Afford It?

Could a “Gene Expression Atlas” Unlock the Secrets of Amyotrophic Lateral Sclerosis?

According to a story from MD Magazine, the team at Spatial Transcriptomics has utilized an innovative computational approach in order to map gene expression on the spinal cords of patients…

Continue Reading Could a “Gene Expression Atlas” Unlock the Secrets of Amyotrophic Lateral Sclerosis?

Enrollment Completed in Achromatopsia and Retinitis Pigmentosa Clinical Trials

ACHM and XLRP Achromatopsia (ACHM) is a rare, inherited retinal disease which causes impaired cone photoreceptor function. Patients experience light sensitivity so extreme that it can cause blindness during the…

Continue Reading Enrollment Completed in Achromatopsia and Retinitis Pigmentosa Clinical Trials

Exciting Gene Therapy Progress in Huntington’s Disease and Spinocerebellar Ataxia

Huntington's Disease & SCAs  Huntington's disease (HD) and spinocerebellar ataxia (SCA) are both neurodegenerative diseases caused by the same type of error in the body's DNA. Essentially, the CAG or…

Continue Reading Exciting Gene Therapy Progress in Huntington’s Disease and Spinocerebellar Ataxia

Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU

According to a story from Market Screener, the specialty pharmaceutical company Santhera Pharmaceuticals recently released an announcement in which the company revealed its intent to file for Conditional Marketing Authorization…

Continue Reading Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU